In NUP98::NSD1 AML cells, targeting the transcriptional co‐regulator SMARCA5, which has been reported as a critical partner of NUP98 fusions in biomolecular condensates, has already been addressed.129. Here, NUP98 is linked to acute myeloid leukemia.